Evidence map›Paper›PMID 26463422›Full record

ArticleBlood2016

B-cell non-Hodgkin lymphoma linked to Coxiella burnetii.

Cléa Melenotte, Matthieu Million, Gilles Audoly, Audrey Gorse, Hervé Dutronc, Gauthier Roland, Michal Dekel, Asuncion Moreno, Serge Cammilleri, Maria Patrizia Carrieri and 7 more

Open access · bronzeAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 91 citations in OpenAlex.

  1. Blood · 2017
    Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. AcuteOpen forum infectious diseases · 2024
    Article
  7. Review
  8. Microorganisms · 2023
    Article
  9. Identification and Characterization of an HtrA Sheddase Produced byInternational journal of molecular sciences · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Pangenomic analysis ofFrontiers in microbiology · 2022
    Article
  15. Review
  16. Article
  17. Review
  18. The link among microbiota, epigenetics, and disease development.Environmental science and pollution research international · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 3 countries.

Cléa MelenotteAix-Marseille Université, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Faculté de Médecine, Unité Mixte (UM) 63, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7278, Institut de Recherche Pour le Développement (IRD) 198, INSERM, U1095, Marseille, France;
Matthieu MillionAix-Marseille Université, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Faculté de Médecine, Unité Mixte (UM) 63, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7278, Institut de Recherche Pour le Développement (IRD) 198, INSERM, U1095, Marseille, France;
Gilles AudolyAix-Marseille Université, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Faculté de Médecine, Unité Mixte (UM) 63, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7278, Institut de Recherche Pour le Développement (IRD) 198, INSERM, U1095, Marseille, France;
Audrey GorseService de Médecine Interne, Nouvel Hôpital Civil, Strasbourg, France;
Hervé DutroncService de Maladies Infectieuses et Tropicales, Groupe Hospitalier Pellegrin, Bordeaux, France;
Gauthier RolandService de Radiologie, Hôpital Nord, Marseille, France;
Michal DekelInfectious Diseases Unit, Tel Aviv Sourasky Medical Center, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel;
Asuncion MorenoService of Infectious Diseases, Hospital Clinic of Barcelona, Institut Biomedical Research August Pi i Sunyer (IDIBAPS), University of Barcelona, Spain;
Serge CammilleriService de Médecine Nucléaire, Hôpital de la Timone, Marseille, France;
Maria Patrizia CarrieriAix Marseille Université, INSERM, UMR912 (Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale [SESSTIM]), IRD, Marseille, France; Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France;
Camelia ProtopopescuAix Marseille Université, INSERM, UMR912 (Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale [SESSTIM]), IRD, Marseille, France; Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France;
Philippe RuminyCentre Henri Becquerel, Institut de Recherche et d'Innovation Biomédicale, INSERM, U918, Rouen, France;
Hubert LepidiAix-Marseille Université, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Faculté de Médecine, Unité Mixte (UM) 63, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7278, Institut de Recherche Pour le Développement (IRD) 198, INSERM, U1095, Marseille, France; Laboratoire d'Anatomopathologie, Hôpital de la Timone, Marseille, France;
Bertrand NadelCentre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, INSERM, U1104, CNRS UMR7280, Marseille, France;
Jean-Louis MegeAix-Marseille Université, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Faculté de Médecine, Unité Mixte (UM) 63, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7278, Institut de Recherche Pour le Développement (IRD) 198, INSERM, U1095, Marseille, France;
Luc XerriCentre de Recherche en Cancérologie de Marseille, Immunity and Cancer, INSERM, U1068, Marseille, France; and Department of bio-pathology, Institut Paoli Calmettes, Marseille, France.
Didier RaoultAix-Marseille Université, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Faculté de Médecine, Unité Mixte (UM) 63, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7278, Institut de Recherche Pour le Développement (IRD) 198, INSERM, U1095, Marseille, France;
Inserm · FRAix-Marseille Université · FREconomic & Social Sciences, Health Systems & Medical Informatics · FRInstitut de Recherche pour le Développement · FRHôpital Civil, Strasbourg · FRHôpital de la Timone · FRHôpital Nord · FRHôpital Pellegrin · FRTel Aviv University · ILUnité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes · FRUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria can induce human lymphomas, whereas lymphoproliferative disorders have been described in patients with Q fever. We observed a lymphoma in a patient with Q fever that prompted us to investigate the association between the 2 diseases. We screened 1468 consecutive patients of the 2004 to 2014 French National Referral Center for Q fever database. The standardized incidence ratios (SIRs) of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) were calculated comparatively to the 2012 Francim Registry. The presence of Coxiella burnetii was tested using immunofluorescence and fluorescence in situ hybridization using a specific 16S ribosomal RNA probe and genomic DNA probe. Seven patients (0.48%) presented mature B-cell lymphoma consisting of 6 DLBCL and 1 FL. An excess risk of DLBCL and FL was found in Q fever patients compared with the general population (SIR [95% confidence interval], 25.4 [11.4-56.4] and 6.7 [0.9-47.9], respectively). C burnetii was detected in CD68(+) macrophages within both lymphoma and lymphadenitis tissues but localization in CD123(+) plasmacytoid dendritic cells (pDCs) was found only in lymphoma tissues. Q fever patients with persistent focalized infection were found more at risk of lymphoma (hazard ratio, 9.35 [1.10-79.4]). Interleukin-10 (IL10) overproduction (P = .0003) was found in patients developing lymphoma. These results suggest that C burnetii should be added to the list of bacteria that promote human B-cell non-Hodgkin lymphoma, possibly by the infection of pDCs and IL10 overproduction. Screening for early lymphoma diagnosis should be considered in the management of patients with Q fever, especially those with persistent focalized infections.

Indexed as

AgedCase-Control StudiesCoxiella burnetiiDendritic CellsFemaleFollow-Up StudiesHumansInterleukin-10Lymphoma, B-CellMacrophagesMaleMiddle AgedPrognosisQ FeverRisk FactorsIL10 protein, humanInterleukin-10

Identifiers

PMID26463422
OpenAlexW2341207234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.